NanoSyrinx is a discovery stage biotech company spun out of the University of Warwick. The company is developing a completely novel method for targeted drug delivery of therapeutic proteins and peptides, to the interiors of cells, to improve efficacy, safety, and economy.

Status current

Associated Fund UK Innovation & Science Seed Fund

Sector Medical / Biotechnology


Associated Team Members

More Companies in Medical / Biotechnology